alkenes has been researched along with Ovarian Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caligiuri, I; Canovese, L; Demitri, N; Gambari, R; Lampronti, I; Rizzolio, F; Santo, C; Scattolin, T; Visentin, F | 1 |
Brouwer, J; den Dulk, H; Marqués-Gallego, P; Mutikainen, I; Reedijk, J; Tanase, S; Turpeinen, U | 1 |
Aubert, G; Bourg, S; Chapleur, Y; Cresteil, T; Dubois, J; Novoa, A; Pellegrini-Moïse, N; Thoret, S | 1 |
3 other study(ies) available for alkenes and Ovarian Neoplasms
Article | Year |
---|---|
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activities on human ovarian cancer cell lines.
Topics: Alkenes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Female; Heterocyclic Compounds; Humans; Inhibitory Concentration 50; Ligands; Methane; Organometallic Compounds; Ovarian Neoplasms; Palladium; Purines | 2018 |
Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand.
Topics: Alkenes; Cisplatin; Crystallography, X-Ray; Diamines; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorescence; Humans; Ovarian Neoplasms; Photochemical Processes; Platinum; Tumor Cells, Cultured | 2009 |
Design, synthesis and antiproliferative activities of biarylolefins based on polyhydroxylated and carbohydrate scaffolds.
Topics: Alkenes; Carbohydrates; Cell Line, Tumor; Cell Proliferation; Female; Humans; Inhibitory Concentration 50; Ovarian Neoplasms; Tubulin | 2011 |